Vanguard Portfolio Management
ANRO icon

Vanguard Portfolio Management’s Alto Neuroscience ANRO Stock Holding History

Vanguard Portfolio Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.78M Buy
+181,101
New +$4.19M ﹤0.01% 2452

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Portfolio Management's ANRO Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 181,101 shares worth $4.78M. The stake represents ﹤0.01% of the portfolio and ranks #2452 among its holdings.

113 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Vanguard Portfolio Management held 181,101 shares of Alto Neuroscience worth $4.78M as of Q2 2026.
  • Alto Neuroscience was a new Vanguard Portfolio Management position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2452 holding.
  • 113 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.